Yanqing Wang

No. 1111 Xianxia Road
Changning, 200336, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 45 publications

Single Cell and Bulk RNA-Seq Profiling of Non-Metastatic Versus Bone-Metastatic Prostate Cancer Identifies the CXCL10-CXCR3 Axis as a Key Determinant of Tumor Microenvironment and Treatment Resistance.

Single Cell and Bulk RNA-Seq Profiling of Non-Metastatic Versus Bone-Metastatic Prostate Cancer Identifies the CXCL10-CXCR3 Axis as a Key Determinant of Tumor Microenvironment and Treatment Resistance.

Journal: Biomedicines

Published: February 02, 2026

EZH2 alters aggressive variant prostate cancer subtype evolution, but is not required for neuroendocrine prostate cancer.

EZH2 alters aggressive variant prostate cancer subtype evolution, but is not required for neuroendocrine prostate cancer.

Journal: bioRxiv : the preprint server for biology

Published: June 04, 2025

Bio-OS: An Integrated Cloud-native Environment for Data-Intensive Biomedical Research.

Bio-OS: An Integrated Cloud-native Environment for Data-Intensive Biomedical Research.

Journal: Genomics, proteomics & bioinformatics

Published: January 22, 2025

Publisher Correction: Integrative proteogenomic profiling of high-risk prostate cancer samples from Chinese patients indicates metabolic vulnerabilities and diagnostic biomarkers.

Publisher Correction: Integrative proteogenomic profiling of high-risk prostate cancer samples from Chinese patients indicates metabolic vulnerabilities and diagnostic biomarkers.

Journal: Nature cancer

Published: October 01, 2024

A Prospective Randomized Trial of Neoadjuvant Chemohormonal Therapy vs Hormonal Therapy in Locally Advanced Prostate Cancer Treated by Radical Prostatectomy.

A Prospective Randomized Trial of Neoadjuvant Chemohormonal Therapy vs Hormonal Therapy in Locally Advanced Prostate Cancer Treated by Radical Prostatectomy.

Journal: The Journal of urology

Published: April 09, 2024

Reply by Authors.

Reply by Authors.

Journal: The Journal of urology

Published: April 09, 2024

Harnessing artificial intelligence for prostate cancer management.

Harnessing artificial intelligence for prostate cancer management.

Journal: Cell reports. Medicine

Published: August 30, 2023

Integrative proteogenomic profiling of high-risk prostate cancer samples from Chinese patients indicates metabolic vulnerabilities and diagnostic biomarkers.

Integrative proteogenomic profiling of high-risk prostate cancer samples from Chinese patients indicates metabolic vulnerabilities and diagnostic biomarkers.

Journal: Nature cancer

Published: June 07, 2023

Early Plasma Circulating Tumor DNA as a Potential Biomarker of Disease Recurrence in Non-metastatic Prostate Cancer.

Early Plasma Circulating Tumor DNA as a Potential Biomarker of Disease Recurrence in Non-metastatic Prostate Cancer.

Journal: Cancer research and treatment

Published: November 28, 2022

Transcriptomic signature defines two subtypes of locally advanced PCa with distinct neoadjuvant therapy benefits.

Transcriptomic signature defines two subtypes of locally advanced PCa with distinct neoadjuvant therapy benefits.

Journal: Frontiers in oncology

Published: November 14, 2022

Early serial circulating tumor DNA sequencing predicts the efficacy of chemohormonal therapy in patients with metastatic hormone-sensitive prostate cancer.

Early serial circulating tumor DNA sequencing predicts the efficacy of chemohormonal therapy in patients with metastatic hormone-sensitive prostate cancer.

Journal: Translational oncology

Published: October 19, 2022

Cogan's syndrome is more than just keratitis: a case-based literature review.

Cogan's syndrome is more than just keratitis: a case-based literature review.

Journal: BMC ophthalmology

Published: July 07, 2022

Showing 1-12 of 45

Last Updated: 09/26/2026